Ten take-home messages on vasopressin use in critically ill patients Ricard Ferrer; Pedro Castro; Carol Lorencio; Josman Monclou; Pilar Marcos; Ana Ochagavia; Juan Carlos Ruíz-Rodríguez; Josep Trenado; Christian Villavicencio; Juan Carlos Yébenes; Lluís Zapata;

Reduction of norepinephrine versus vasopressin in the stabilization phase of septic shock: RENOVA clinical trial Cássio Mallmann; Thizá Maria Bianchi Galiotto; Michele Salibe de Oliveira; Rafael Barberena Moraes;

Factors associated with vasoplegic shock in the postoperative period of cardiac surgery and influence on morbidity and mortality of the use of arginine vasopressin as rescue therapy María Barrera Sánchez; Cristina Royo Villa; Pablo Ruiz de Gopegui Miguelena; Pablo Gutiérrez Ibañes; Andrés Carrillo López;